Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors
- 1 August 2020
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 199, 112391
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81922064)
- National Natural Science Foundation of China (91853109)
- National Natural Science Foundation of China (81874290)
This publication has 146 references indexed in Scilit:
- Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjectsFluids and Barriers of the CNS, 2013
- Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injuryExperimental Neurology, 2012
- DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and AutophagyMolecular Cell, 2011
- Rictor Forms a Complex with Cullin-1 to Promote SGK1 Ubiquitination and DestructionMolecular Cell, 2010
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their SurvivalCell, 2009
- Discovery of Drug-Resistant and Drug-Sensitizing Mutations in the Oncogenic PI3K Isoform p110αCancer Cell, 2008
- Hsp70 associates with Rictor and is required for mTORC2 formation and activityBiochemical and Biophysical Research Communications, 2008
- Rapamycin and mTOR kinase inhibitorsJournal of Chemical Biology, 2008
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002